LivaNova PLC (NASDAQ:LIVN) Given Consensus Recommendation of "Buy" by Brokerages

Shares of LivaNova PLC (NASDAQ:LIVN - Get Free Report) have received a consensus recommendation of "Buy" from the seven ratings firms that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, five have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among brokers that have covered the stock in the last year is $69.17.

Several research analysts have recently issued reports on LIVN shares. Needham & Company LLC restated a "buy" rating and issued a $75.00 price objective on shares of LivaNova in a research note on Tuesday, January 28th. Mizuho reduced their price target on shares of LivaNova from $80.00 to $70.00 and set an "outperform" rating for the company in a research report on Thursday, October 31st. StockNews.com upgraded shares of LivaNova from a "buy" rating to a "strong-buy" rating in a research note on Friday, February 14th. Finally, Robert W. Baird increased their price objective on shares of LivaNova from $66.00 to $72.00 and gave the stock an "outperform" rating in a research note on Thursday, October 31st.

Insider Activity

In related news, Director Francesco Bianchi sold 1,250 shares of the firm's stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $50.99, for a total transaction of $63,737.50. Following the sale, the director now owns 7,522 shares in the company, valued at approximately $383,546.78. This trade represents a 14.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.27% of the company's stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Russell Investments Group Ltd. grew its position in shares of LivaNova by 17.1% during the 4th quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company's stock valued at $70,000 after acquiring an additional 219 shares during the period. Sterling Capital Management LLC boosted its position in LivaNova by 800.6% during the fourth quarter. Sterling Capital Management LLC now owns 1,621 shares of the company's stock worth $75,000 after purchasing an additional 1,441 shares in the last quarter. Central Pacific Bank Trust Division grew its holdings in LivaNova by 21.2% in the fourth quarter. Central Pacific Bank Trust Division now owns 4,117 shares of the company's stock valued at $191,000 after purchasing an additional 720 shares during the period. Vestcor Inc purchased a new stake in shares of LivaNova in the fourth quarter valued at approximately $204,000. Finally, Optimize Financial Inc acquired a new position in shares of LivaNova during the 4th quarter worth approximately $208,000. Institutional investors and hedge funds own 97.64% of the company's stock.

LivaNova Stock Performance

LIVN stock traded up $0.26 during midday trading on Friday, reaching $47.47. The stock had a trading volume of 444,292 shares, compared to its average volume of 443,186. The firm has a fifty day simple moving average of $48.20 and a two-hundred day simple moving average of $49.55. LivaNova has a 52-week low of $43.15 and a 52-week high of $64.47. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.87 and a current ratio of 3.37. The stock has a market cap of $2.58 billion, a PE ratio of 113.02 and a beta of 1.00.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.